Educational resources to assist the medical community in cannabinoid medicine

Federal Government Therapeutic Goods Administration


  1. Authorised Prescriber – authorisation of doctor for a cohort of patients
  2. Special Access Scheme (SAS) – authorisation for an individual patient
    Guidance for health practitioners and sponsors
    Special Access Scheme forms
    Contact for enquiries and submission of applications
    • Category A is a notification pathway for terminally ill patients and may only be used for imported products;
    • Category B is an application pathway where the patients do not fit Category A and the product does not have an established history of use under Category C.  This is likely the most applicable SAS Category for medicinal cannabis
    • Category C is a notification pathway where products have an established history of use and are listed together with their indications